Vimarsana
Biggest News Aggregation in the World

Astrazeneca Stock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Astrazeneca Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Astrazeneca Stock Today - Breaking & Trending Today

IMFINZI (durvalumab) plus LYNPARZA (olaparib) and IMFINZI alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy - Vimarsana News

IMFINZI (durvalumab) plus LYNPARZA (olaparib) and IMFINZI alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy

Published: May 26, 2023

26.05.2023 - Positive high-level results from the DUO-E Phase III trial showed IMFINZI (durvalumab) in combination with platinum-based chemotherapy followed by either IMFINZI plus LYNPARZA (olaparib) or IMFINZI alone as maintenance therapy both demonstrated a ...

Source: wallstreet-online.de
Related Topics:
United StatesUnited KingdomSusan GalbraithShannonn WestinInternational Journal Of Gynecological PathologyMerck Co IncUs Electronic Health RecordsAmerican Cancer SocietyUniversity Of Texas Md Anderson Cancer CenterWorld Cancer Research Fund InternationalGynecologic OncologyReproductive MedicineCancer CenterExecutive Vice PresidentFatal Immune Mediated AdverseMediated NephritisFull Prescribing InformationAcute Myeloid LeukemiaThromboembolic EventsFetal ToxicityFirst Line MaintenanceAdvanced OvarianFirst Line Maintenance Advanced Ovarian CancerMaintenance Recurrent OvarianAdjuvant Treatment
Where next for AstraZeneca stock ahead of Q1 2022 earnings - Vimarsana News

Where next for AstraZeneca stock ahead of Q1 2022 earnings

Published: April 27, 2022

AstraZeneca’s results will benefit from the acquisition of Alexion, but questions remain over its Covid-19 drugs and the outlook in China.

Source: cityindex.co.uk
Related Topics:
Alexion PharmaceuticalsNational Reimbursement Drug ListFriday AprilVolume Based ProcurementCity IndexDemo TradingAstrazeneca StockAstrazeneca Share PriceAmzn StockMzn Share PriceAstrazeneca Covid 19 VaccineAstrazeneca VaccineVaccine StocksStrazeneca To Spin Off Vaccine BusinessStrazeneca Q1 2022 Earnings PreviewStrazeneca Earnings PreviewStrazeneca Q1Pfizer StockPfe StockModerna StockMrna StockStrazeneca In ChinaMzn Technical AnalysisOw To Trade AstrazenecaOw To Trade Azn Stock
Where next for the AstraZeneca share price ahead of Q4 earnings - Vimarsana News

Where next for the AstraZeneca share price ahead of Q4 earnings

Published: February 8, 2022

Markets believe AstraZeneca can continue to deliver strong double-digit growth in 2022, but will the pharma giant’s outlook meet expectations this week?

Source: cityindex.co.uk
Related Topics:
Alexion PharmaceuticalsThursday FebruaryCity IndexAstrazeneca Share PriceAstrazeneca SharesAstrazeneca StockMzn SharesMzn Share PriceAmzn StockAstrazeneca Q4Strazeneca EarningsAstrazeneca VaccineMzn Technical AnalysisFe Share PricePfe StockEfe SharesPfizer SharesPfizer Share PricePfizer Stock